Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion-SR for Smoking Behaviors in Schizophrenia
NCT00218231Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Jan 2004
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupropion in Tobacco Use Disorder (TUD), sponsored by National Institute on Drug Abuse. Started Jan 2004; status: completed.
02
Drugs
bupropion
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00218231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00218231.